Cargando…
Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-β1/Smad Signalling Pathway
It has been recently shown that loureirin A (LA), a major active component of resina draconis, might be effective in the prevention and treatment of liver fibrosis. We examined whether LA could inhibit the formation of keloids. To investigate the pharmacological effects of loureirin A on keloid form...
Autores principales: | Ma, Hui, Duan, Xingwu, Zhang, Runtian, Li, Hang, Guo, Yang, Tian, Ye, Huang, Min, Chen, Guangshan, Wang, Zi, Li, Lingling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307331/ https://www.ncbi.nlm.nih.gov/pubmed/35873644 http://dx.doi.org/10.1155/2022/8661288 |
Ejemplares similares
-
Loureirin B Alleviates Myocardial Ischemia/Reperfusion Injury via Inhibiting PAI-1/TGF-β1/Smad Signaling Pathway
por: Kong, Fei, et al.
Publicado: (2022) -
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways
por: Wang, Wenbo, et al.
Publicado: (2016) -
STAT3 selectively interacts with Smad3 to antagonize TGF-β signaling
por: Wang, Gaohang, et al.
Publicado: (2015) -
Loureirin B Exerts its Immunosuppressive Effects by Inhibiting STIM1/Orai1 and K(V)1.3 Channels
por: Shi, Shujuan, et al.
Publicado: (2021) -
The immunosuppressive effects and mechanisms of loureirin B on collagen-induced arthritis in rats
por: Zou, Yan, et al.
Publicado: (2023)